Pyrimidyl sulphone amide derivatives as chemokine receptor...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 239/48 (2006.01) A61K 31/506 (2006.01) A61K 31/5377 (2006.01) A61P 11/00 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) C07D 239/69 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/12 (2006.01)

Patent

CA 2493785

A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.

La présente invention concerne un composé représenté par la formule générale (I), l'un de ses sels, solvates ou esters hydrolysables in vivo, pharmaceutiquement admis. Ces composés conviennent particulièrement au traitement de l'asthme, de rhinite allergique, de bronchopneumopathie chronique obstructive, de maladie intestinale inflammatoire, de syndrome de côlon irritable, d'ostéoarthrite, d'ostéoporose, de polyarthrite rhumatoïde, de psoriasis ou de cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrimidyl sulphone amide derivatives as chemokine receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidyl sulphone amide derivatives as chemokine receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidyl sulphone amide derivatives as chemokine receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2015398

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.